The abstract is read at the publisher; the summary is JClub's.
A musculoskeletal Human Cell Atlas should be medicalised to translate cellular maps into clinically actionable knowledge, enabling mechanism-led diagnosis and patient stratification.
- Why it matters: Current MSK diagnostic labels are common, heterogeneous, and often insufficiently stratified, masking distinct cellular mechanisms and therapeutic vulnerabilities.
- What they did: The review outlines how single-cell, single-nucleus, spatial, and multiomic approaches map MSK tissues across development, ageing, and health-to-disease, then connect atlases to phenotypes, biospecimens, genetic risk, biomarkers, perturbation experiments, and interventional trials.
- The result: By reframing disease taxonomy around pathogenic cell states and using trial outcomes to iterate, the MSK-HCA provides a shared coordinate system for linking genes, cells, and microenvironments to precision rheumatology and regenerative MSK therapy.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.